Medicrea received FDA 510(k) clearances for its PASS® XS posterior fixation and LigaPASS® XS band connector components, designed to address spinal deformities in small stature patients.
Strategic transactions year to date in 2016 represent participants from OEMs, Suppliers, Distributors and Private Equity, with values ranging from $10 million to $1 billion.
Data collection is paramount to the success of any orthopaedic device. What happens to the much-coveted postmarket data/initiative during and after a merger or acquisition? We posed this question to Vicki Anastasi, Vice President & Global Head, Medical Devices & Diagnostics Research with ICON plc.
Paradigm BioDevices completed its 25,000th case with the QuickDraw MIS Bone Harvester™. A single-use, sterile version of the system is slated for launch next week, and CE Mark approval is expected by year-end.
Randomized study results indicate that Safe Orthopaedics’ single-use spine surgical instruments yielded an 80% decrease in pre- and post-operative times.
Isto Technologies acquired Arteriocyte Medical Systems, forming Isto Biologics. The new entity will offer evidence-based solutions for spine and orthopaedic applications. Terms were not disclosed.
CollPlant received CE Mark approval for Vergenix™STR soft tissue repair matrix for the treatment of tendinopathy. EU launch is anticipated in coming months.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more